Investigating the association between blood lipid profiles and insulin resistance and β-cell function indices in pregnant women.
Feng Jie J, Xu Xinyue X, Tian Zeyang Z, Chen Fangbo F et al.
This study aimed to examine the associations between first-trimester lipid markers and second-trimester insulin resistance (IR) and pancreatic β-cell function (BCF) indices in pregnant women. An exploratory aim was to explore the apparent discrimination of lipid markers for cohort-defined low insulin sensitivity. This retrospective secondary analysis used prospectively collected cohort data from 1202 pregnant women in Beijing, China. Lipids were measured at 4-8 weeks of gestation, and a 75 g oral glucose tolerance test was performed at 24-28 weeks. The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and the Matsuda index were analyzed as continuous measures of IR and insulin sensitivity. BCF was assessed using surrogate indices: the Homeostatic Model Assessment of β-cell function (HOMA-β) and the 60-min insulinogenic index (IGI60). Linear-regression models adjusted for age and early-pregnancy body mass index examined the associations between each lipid marker and continuous HOMA-IR and the Matsuda index as the primary analyses and with HOMA-β and IGI60 as the secondary analyses. Binary logistic-regression and receiver operating characteristic analyses of cohort-defined low insulin sensitivity were exploratory. After adjustment for age and early-pregnancy body mass index, all seven lipid markers were significantly associated with continuous HOMA-IR and the Matsuda index (all nominal P < 0.05). No statistically significant associations were observed with the surrogate β-cell-function indices HOMA-β or IGI60. In the exploratory analyses, the lipid markers were associated with the cohort-defined low-Matsuda category. Triglycerides/high-density lipoprotein cholesterol had the highest observed area under the curve in the total population (0.723; 95% confidence interval 0.689-0.756). The exploratory cutoff selected by maximizing Youden's index was 0.65, with a sensitivity of 74.1% and a specificity of 62.5%. First-trimester lipid markers were associated with second-trimester IR and insulin-sensitivity indices, whereas no statistically significant associations were observed with the surrogate BCF indices used in this study. Triglycerides/high-density lipoprotein cholesterol showed moderate apparent discrimination for cohort-defined low insulin sensitivity and should be considered a hypothesis-generating candidate marker requiring external validation.